Shield Therapeutics plc (SHIEF)
OTCMKTS
· Delayed Price · Currency is USD
0.0340
-0.0005 (-1.45%)
At close: Jan 31, 2025
Shield Therapeutics Revenue
In the year 2024, Shield Therapeutics had annual revenue of $32.18M with 145.93% growth. Shield Therapeutics had revenue of $20.05M in the half year ending December 31, 2024, with 594.90% growth.
Revenue
32.18M
Revenue Growth
+145.93%
P/S Ratio
1.05
Revenue / Employee
510.79K
Employees
63
Market Cap
33.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 32.18M | 19.10M | 145.93% |
| Dec 31, 2023 | 13.09M | 7.59M | 137.95% |
| Dec 31, 2022 | 5.50M | 3.44M | 167.35% |
| Dec 31, 2021 | 2.06M | -12.12M | -85.50% |
| Dec 31, 2020 | 14.18M | 13.23M | 1,389.24% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| American Oncology Network | 1.76B |
Shield Therapeutics News
- 4 months ago - UK Stock Market News: GSK, DCC, Shield Therapeutics - The Armchair Trader
- 7 months ago - Small Cap Stocks: Microsalt, Proton Motor Power, Eckoh - The Armchair Trader
- 7 months ago - Small Cap Stocks: Seascape Energy, Arkle, Mirriad - The Armchair Trader
- 4 years ago - OTC Markets Group Welcomes Shield Therapeutics PLC to OTCQX - PRNewsWire